Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients
Conditions
Clostridioides Difficile Infection · Recurrent Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CH Annecy Genevois Service de Maladies infectieuses, Annecy, France
Contact: Principal Investigator (Emilie PIET, MD)Service d'hépato-gastroentérologie - CHU Estaing, Clermont-Ferrand, France
Contact: Principal Investigator (Julien SCANZI, MD)CHU Grenoble Service Maladies infectieuses et tropicales, Grenoble, France
Contact: Principal Investigator (Salomé GALLET, MD)CHU Lille Unité des Maladies Infectieuses et tropicales, Lille, France
Contact: Principal Investigator (Sarah STABLER, MD)Service d'Hépato-gastroentérologie Hôpital de la Croix Rousse, Lyon, France
Contact: Principal Investigator (Nicolas BENECH, MD)APHM La Timone Service de Maladies infectieuses, Marseille, France
Contact: Principal Investigator (Nadim CASSIR, MD)Service d'hépato-gastroentérologie - Hôpital Saint Antoine (APHP), Paris, France
Contact: Principal Investigator (Paul MCLELLAN, MD)Service d'infectiologie - Hôpital Nord / CHU Saint Etienne, Saint-Etienne, France
Contact: Study coordinator (Elisabeth BOTHELO-NEVERS, Pr) · elisabeth.botelho-nevers@chu-st-etienne.fr · 04 77 12 77 89Contact: Principal Investigator (Elisabeth BOTHELO-NEVERS, Pr)Service de médecine interne - Pôle des maladies de l'appareil digestif - CHU de Toulouse, Toulouse, France
Contact: Principal Investigator (Laurent ALRIC, Pr)Service de Maladies Infectieuses - CH de Valence, Valence, France
Contact: Principal Investigator (Amélie DUREAULT, MD)
Study leads
Nicolas BENECH, MD
Principal Investigator
Hospices Civils de Lyon